The FORTIS trial is investigating whether AT845, an adeno-associated virus (AAV) therapy, can deliver a functional copy of the acid alpha-glucosidase (GAA) gene directly in muscle cells in adults ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback